Ovarian Cancer
Biomarker-Focused Strategies Improve Outcomes in Gynecologic Malignancies
Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, according to Ritu Salani, MD, MBA.
Read More
Advancing the Treatment of Cervical and Endometrial Cancers
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
Listen
ChatGPT Scores High for Genetic Counseling in Gynecologic Cancers
ChatGPT was able to answer general questions about genetic counseling for gynecologic cancers, but some obstacles still remain.
Precision Medicine Guiding Ovarian Cancer Treatment
Sarah M. Temkin, MD leads discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.
McHale Analyzes the Benefits and Challenges of PARP Inhibition for Certain Patients With Advanced Ovarian Cancer
At a live virtual event, Michael McHale, MD, led a roundtable discussion on the use of PARP inhibition therapy for patients with advanced ovarian cancer.
FDA Grants Full Approval to Mirvetuximab for Platinum-Resistant Ovarian Cancer
Mirvetuximab soravatansine is now FDA-approved for the treatment of patients with folate receptor alpha-positive, platinum-resistant ovarian cancer